This FDA-guided pivotal trial tested the Lenire® device for tinnitus by adding tongue stimulation to sound therapy.
This FDA-guided pivotal trial tested the Lenire® device for tinnitus by adding tongue stimulation to sound therapy.
This FDA-guided pivotal trial tested the Lenire® device for tinnitus by adding tongue stimulation to sound therapy. Among 112 participants, those with moderate or worse tinnitus experienced significantly greater improvement than with sound alone. No serious adverse events occurred, and most users reported satisfaction. Findings support bimodal neuromodulation as a safe, effective tinnitus therapy.
Use the full description to understand the study design, methods, and the limits of the findings.
A pivotal multi-site trial demonstrated that combining sound therapy with electrical tongue stimulation using the Lenire® device significantly improved tinnitus symptoms among adults with moderate to severe tinnitus, achieving a 58.6% responder rate compared to 43.2% with sound-only therapy. The study led to FDA De Novo approval of the Lenire device.
Open the original publication for the complete methods, outcomes, and source material.
The study provides moderate to strong evidence for the efficacy of combining sound with tongue stimulation for tinnitus treatment. While the design is robust for a single-arm trial, the lack of randomization and blinding introduces potential biases. The study is relevant to seniors but could benefit from more detailed age-specific analysis.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 7.5/10 | |
| Bias & Methods | 6.5/10 | |
| Statistical Integrity | 8.0/10 | |
| Transparency | 8.0/10 | |
| Conflict of Interest Disclosure | 9.0/10 | |
| Replication / External Validation | 5.0/10 | |
| Relevance to Seniors | 7.0/10 | |
| Journal Quality | 9.0/10 |
The study's approval by the FDA De Novo process adds credibility, but further independent replication would strengthen the evidence base. The lack of serious adverse events is a positive aspect for senior safety.
Build a personalized plan using research-backed studies, conditions, and treatments.